Compass Therapeutics (CMPX) Other Non Operating Income (2019 - 2026)

Compass Therapeutics (CMPX) has 8 years of Other Non Operating Income data on file, last reported at $2.0 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non Operating Income rose 48.69% year-over-year to $2.0 million; the trailing twelve-month figure through Mar 2026 stood at $7.0 million (up 6.03% YoY), and the FY2025 full-year result was $6.4 million, down 12.41% from the prior year.
• Other Non Operating Income eased to $2.0 million in Q1 2026, from $2.3 million in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $2.3 million in Q4 2025 to a low of $20000.0 in Q1 2022.
• A 5-year average of $1.5 million and a median of $1.8 million in 2024 frame the typical range for Other Non Operating Income.
• Across the five-year window, Other Non Operating Income jumped 18385.71% in 2022 and plunged 39.82% in 2025, its largest moves.
• Tracing CMPX's Other Non Operating Income over 5 years: stood at $1.3 million in 2022, then jumped by 52.86% to $2.0 million in 2023, then decreased by 22.09% to $1.5 million in 2024, then surged by 47.57% to $2.3 million in 2025, then decreased by 12.84% to $2.0 million in 2026.
• Business Quant data shows CMPX's Other Non Operating Income at $2.0 million in Q1 2026, $2.3 million in Q4 2025, and $1.6 million in Q3 2025.